The FDA has approved #Hovilpri (#pritelivir) for adults with weakened immune systems who have mucocutaneous lesions caused by HSV infection that have not responded to other treatments.
🧪Pritelivir for research use from MedChemExpress: https://www.medchemexpress.com/BAY-57-1293.html